With 10.9% percent of adult Montanans diagnosed with diabetes, new remote patient monitoring solution will provide accessible care for those in rural settings Columbia, MD – July 1, 2020 –…
Read ArticleColumbia, MD June 11, 2020 – Welldoc®, revolutionizing digital health with the first FDA-cleared Software as a Medical Device (SaMD) for diabetes, today announced the expansion of an agreement with…
Read Article
Marks 8th FDA clearance for BlueStar, the only reimbursable Software as a Medical Device for diabetes that integrates with all of a patient’s existing devices Columbia, MD – June 3,…
Read Article
Columbia, MD – March 11, 2020 – Welldoc, a leading digital health company, announced today a collaboration with Dexcom, the global leader in continuous glucose monitoring (CGM) systems for people…
Read ArticlePartnership ensures bidirectional integration with EHRs and insights available at the point of care MADISON, WI—February 25, 2020—Welldoc, a leading digital health company revolutionizing chronic disease management, announced today its…
Read ArticleThis is Welldoc’s 8th 510(k) filing to the U.S. Food and Drug Administration Columbia, MD – January 16, 2020 – Welldoc, a leading digital health company, announced today the filing…
Read ArticleFuture-focused formulary for digital health, medicine and therapeutics will allow employers and health plans to effectively manage a fast-growing segment of health care while improving access for patients. ST. LOUIS,…
Read ArticleDevelop and commercialize digital health solutions globally for multiple therapeutic areas, including in Japan for diabetes patients TOKYO and Columbia, Maryland, November 20, 2019 – Astellas Pharma Inc. (TSE: 4503,…
Read Article